COFCO Biotechnology to hold extraordinary general meeting

COFCO Biotechnology Co., Ltd. (SZSE:000930) announced its upcoming fifth extraordinary general meeting for 2025, scheduled for December 15, 2025. The meeting will feature both an in-person gathering at the company's Beijing headquarters and online voting platforms via the Shenzhen Stock Exchange. Key proposals include the abolition of the company's supervisory board and its rules, along with revisions to the company's articles of association, shareholder meeting rules, and board of directors meeting rules.

Shareholders registered by December 10, 2025, will be eligible to vote. Online voting will be available from 9:15 to 15:00 on December 15, 2025, through the Shenzhen Stock Exchange's trading and internet voting systems. All proposals will be subject to a common resolution, requiring approval from two-thirds of the voting rights held by shareholders present.

The meeting agenda, initially submitted by the company's ninth board of directors, was first disclosed on November 29, 2025. COFCO Biotechnology stated it will separately tally and release the voting results for small and medium-sized investors.